These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21598749)

  • 1. Clinical roundtable monograph. Integrating recent data in managing adverse events in the treatment of hepatocellular carcinoma.
    Gish RG; Abou-Alfa GK; Tong MJ
    Clin Adv Hematol Oncol; 2010 Sep; 8(9):2 p preceding 4-15. PubMed ID: 21598749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating recent data in managing adverse events in the treatment of hepatocellular carcinoma.
    Gish RG; Abou-Alfa GK; Tong MJ
    Gastroenterol Hepatol (N Y); 2010 Sep; 6(9 Suppl 16):1-16. PubMed ID: 22423222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical management and case reports for the treatment of hepatocellular carcinoma with sorafenib.
    Frenette CT; Frederick RT; Gish RG
    J Clin Gastroenterol; 2011 Sep; 45(8):733-7. PubMed ID: 20930642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.
    Wörns MA; Weinmann A; Pfingst K; Schulte-Sasse C; Messow CM; Schulze-Bergkamen H; Teufel A; Schuchmann M; Kanzler S; Düber C; Otto G; Galle PR
    J Clin Gastroenterol; 2009; 43(5):489-95. PubMed ID: 19247201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic treatment in hepatocellular carcinoma; 'A small step for man...'.
    Witjes CD; Verhoef C; Verheul HM; Eskens FA
    Neth J Med; 2009 Mar; 67(3):86-90. PubMed ID: 19307678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic therapy of hepatocellular carcinoma: are we making progress?
    Roxburgh P; Evans TR
    Adv Ther; 2008 Nov; 25(11):1089-104. PubMed ID: 18972075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging strategies in the treatment of advanced hepatocellular carcinoma: the role of targeted therapies.
    Lord R; Suddle A; Ross PJ
    Int J Clin Pract; 2011 Feb; 65(2):182-8. PubMed ID: 21235699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomized trials.
    Zhang T; Ding X; Wei D; Cheng P; Su X; Liu H; Wang D; Gao H
    Anticancer Drugs; 2010 Mar; 21(3):326-32. PubMed ID: 20016366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hepatocellular carcinoma.
    Blum HE
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):129-45. PubMed ID: 15757809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial.
    Rimassa L; Santoro A
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):739-45. PubMed ID: 19496710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment options for hepatocellular carcinoma.
    Sandhu DS; Tharayil VS; Lai JP; Roberts LR
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):81-92. PubMed ID: 19072372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorafenib for the treatment of unresectable hepatocellular carcinoma.
    Kane RC; Farrell AT; Madabushi R; Booth B; Chattopadhyay S; Sridhara R; Justice R; Pazdur R
    Oncologist; 2009 Jan; 14(1):95-100. PubMed ID: 19144678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel advancements in the management of hepatocellular carcinoma in 2008.
    Llovet JM; Bruix J
    J Hepatol; 2008; 48 Suppl 1():S20-37. PubMed ID: 18304676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current treatment for hepatocellular carcinoma.
    Cahill BA; Braccia D
    Clin J Oncol Nurs; 2004 Aug; 8(4):393-9. PubMed ID: 15354926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the treatment of hepatocellular carcinoma.
    Singal AG; Marrero JA
    Curr Opin Gastroenterol; 2010 May; 26(3):189-95. PubMed ID: 20224395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced HCC: emerging molecular therapies.
    Finn RS
    Minerva Gastroenterol Dietol; 2012 Mar; 58(1):25-34. PubMed ID: 22419002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy.
    Kudo M
    Oncology; 2008; 75 Suppl 1():1-12. PubMed ID: 19092266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited hepatocellular carcinoma.
    Villanueva A; Newell P; Hoshida Y
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):725-34. PubMed ID: 20955973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?
    Lencioni R; Chen XP; Dagher L; Venook AP
    Oncologist; 2010; 15 Suppl 4():42-52. PubMed ID: 21115580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and feasibility of using sorafenib in recurrent hepatocellular carcinoma after orthotopic liver transplantation.
    Kim R; El-Gazzaz G; Tan A; Elson P; Byrne M; Chang YD; Aucejo F
    Oncology; 2010; 79(1-2):62-6. PubMed ID: 21071991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.